Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003748priorityCriticalpatent/ECSP003748A/en
Publication of ECSP003748ApublicationCriticalpatent/ECSP003748A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere al uso de ciertos derivados 4-sustituidos de la pirimidina como antagonistas de los receptores mGluR1, a nuevos derivados 4-sustituidos de la pirimidina a formulaciones farmacéuticas que comprenden derivados 4-sustituidos de la pirimidina, a un procedimiento para preparar derivados 4-sustituidos de la pirimidina y a intermedios útiles en la preparación de derivados 4-sustituidos de la pirimidina.The present invention relates to the use of certain 4-substituted pyrimidine derivatives as antagonists of mGluR1 receptors, to new 4-substituted pyrimidine derivatives to pharmaceutical formulations comprising 4-substituted pyrimidine derivatives, to a process for preparing 4-substituted derivatives of pyrimidine and intermediates useful in the preparation of 4-substituted derivatives of pyrimidine.